Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasmin Leshem
Observed name:
Y. Leshem
Institutions:
Tel Aviv University,
Tel Aviv Sourasky Medical Center
Observed institutions:
National Institutes of Health,
Tel Aviv University,
Technion – Israel Institute of Technology,
Tel Aviv Sourasky Medical Center,
Sheba Medical Center,
National Cancer Institute,
Center for Cancer Research,
Weizmann Institute of Science
show all 8
ORCID:
0000-0002-8264-1308
Observed ORCID:
0000-0002-8264-1308
OpenAlex ID:
A5090928026
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
2014
·
Barliz Waissengrin
, Damien Urban
, et al.
·
Journal of Pain and Symptom Management
·
83
PDF
Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient’s Bedside to Evaluation in Preclinical Models
2019
·
Yasmin Leshem
, Ira Pastan
·
Toxins
·
53
PDF
Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity
2017
·
Yasmin Leshem
, James O'Brien
, et al.
·
Cancer Immunology Research
·
48
The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?
2022
·
Barliz Waissengrin
, Yasmin Leshem
, et al.
·
European Journal of Cancer
·
32
SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma Tumors
2018
·
Yasmin Leshem
, Emily M. King
, et al.
·
Toxins
·
32
PDF
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
2024
·
Moran Gvili Perelman
, Rafael Y. Brzezinski
, et al.
·
Cardio-Oncology
·
30
PDF
Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer
2023
·
Yasmin Leshem
, Yardenna Dolev
, et al.
·
Cancer
·
25
PDF
Improving the In Vivo Efficacy of an Anti-Tac (CD25) Immunotoxin by Pseudomonas Exotoxin A Domain II Engineering
2018
·
Gilad Kaplan
, Ronit Mazor
, et al.
·
Molecular Cancer Therapeutics
·
18
Outcomes of Fetuses With Umbilical Cord Cysts Diagnosed During Nuchal Translucency Examination
2011
·
Yinon Gilboa
, Zvi Kivilevitch
, et al.
·
Journal of Ultrasound in Medicine
·
15
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab
2023
·
Yasmin Leshem
, Tal Etan
, et al.
·
International Journal of Cardiology
·
11
The predictive value of serial troponin measurements in patients treated with immune checkpoint inhibitors
2025
·
Moran Gvili Perelman
, Rafael Y Brzezinski
, et al.
·
The Oncologist
·
9
PDF
Squamous cell carcinoma arising in chronically damaged skin (Marjolin’s Ulcer): still an unmet need in the era of immunotherapy
2024
·
Mor Miodovnik
, Yardenna Dolev
, et al.
·
The Oncologist
·
6
PDF
Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy
2019
·
Tapan K. Bera
, Wenlong Liu
, et al.
·
Journal of Immunotherapy
·
4
The use of medical cannabis concomitantly with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC): A sigh of relief?
2022
·
Barliz Waissengrin
, Yasmin Leshem
, et al.
·
Journal of Clinical Oncology
·
3
BRAF and MEK inhibition beyond dabrafenib–trametinib in advanced thyroid cancer: a real-world case series
2026
·
Tzahi Yamin
, Oded Cohen
, et al.
·
Frontiers in Endocrinology
·
2
PDF
Ulcer-related cutaneous squamous cell carcinoma: New kid on the block.
2024
·
Mor Miodovnik
, Inna Ospovat
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer
2023
·
Yasmin Leshem
, Yardena Dolev
, et al.
·
Endocrine Abstracts
·
2
Abstract 58: Local intratumoral treatment with anti-mesothelin Immunotoxins overcomes resistance to anti-CTLA-4 therapy
2017
·
Yasmin Leshem
, Xiu-fen Liu
, et al.
·
Cancer Research
·
2
Rare occurrence of immunotherapy-related gastritis and duodenitis in a single tertiary medical center: a diagnostic challenge
2025
·
Tal Etan
, Iddo Bar-Yishay
, et al.
·
The Oncologist
·
1
PDF
In reply to: “Letter to the editor in response to the article:‘Squamous cell carcinoma arising in chronically damaged skin (Marjolijn’s Ulcer)’”
2025
·
Mor Miodovnik
, Yardenna Dolev
, et al.
·
The Oncologist
·
1
PDF
Cancer of the Small Intestine
2024
·
Yardenna Dolev
, Yasmin Leshem
, et al.
·
1
PDF
Pseudo pulmonary embolism in cancer patients
2014
·
Ophira Salomon
, Yasmin Leshem
, et al.
·
Blood Coagulation & Fibrinolysis
·
1
Incidental Coronary Artery Calcification on Simulation Breast Radiotherapy Imaging and Risk of Subsequent Ischemic Heart Disease:A Missed Opportunity?
2026
·
Inbal Golomb
, Yasmin Leshem
, et al.
·
Practical Radiation Oncology
Efficacy and toxicity of neoadjuvant chemotherapy versus chemo-immunotherapy in triple-negative breast cancer patients with and without germline BRCA mutations
2026
·
Tal Etan
, Lior Cohen
, et al.
·
Breast Cancer Research and Treatment
PDF
A phase II study evaluating treatment discontinuation of dual anti-HER2 therapy in metastatic HER2-positive breast cancer after five years of sustained complete response (FREEDOME-trial).
2026
·
Albert Grinshpun
, Amir Sonnenblick
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
47
Citation count:
380
H-index:
10
I10-index:
10
Year
Topic
Type